93
Participants
Start Date
January 24, 2018
Primary Completion Date
May 19, 2022
Study Completion Date
May 19, 2022
rhPTH (1-84)
rhPTH (1-84) SC injection.
Placebo
Placebo QD SC injection.
Università Campus Bio Medico Di Roma, Roma
Oslo Universitetssykehus HF Rikshospitalet, Oslo
Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden
UZ Leuven, Leuven
Odense Universitetshospital, Odense C
Haukeland Universitetssykehus, Bergen
Aarhus Universitetshospital, Aarhus N
UZ Gent, Ghent
Children's Hospital of Philadelphia, Philadelphia
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
Hopital Jean Minjoz, Besançon
Physicians East PA, Greenville
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Sahlgrenska Universitetssjukhuset, Gothenburg
Ohio State University Wexner Medical Center, Columbus
Michigan Bone and Mineral Clinic, Detroit
CHU Angers, Angers
Universita di Firenze, Dipartimento di Chirurgia e Medicina Traslazionale (DCMT), Florence
Mayo Clinic - PPDS, Rochester
CHRU Lille, Lille
University of Chicago, Chicago
CHU Bicêtre, Le Kremlin-Bicêtre
Nova Scotia Health Authority (Capital District Health Authority), Halifax
Bone Research and Education Centre, Oakville
CHU de Quebec-Universite Laval, Québec
Eastern Health - Health Sciences Center- General Hospital, St. John's
VU Medisch Centrum, Amsterdam
Leids Universitair Medisch Centrum, Leiden
Oslo Universitetssykehus Aker, Oslo
Centro Hospitalar E Universitário de Coimbra EPE, Coimbra
Unidade Local de Saúde de Matosinhos SA, Matosinhos Municipality
Centro Hospitalar de São João, E.P.E., Porto
C.H. Regional Reina Sofia - PPDS, Córdoba
Ninewells Hospital - PPDS, Dundee
Norfolk and Norwich University Hospital, Norwich
Queen Elizabeth Hospital, Birmingham
Leicester Royal Infirmary, Leicester
Manchester Royal Infirmary - PPDS, Manchester
Lead Sponsor
Shire
INDUSTRY